Sfoglia per Rivista
Information on center characteristics as costs' determinants in Multicenter clinical trials: Is modeling center effect worth the effort?
2009-01-01 PETRINCO M; PAGANO E; DESIDERI A; BIGI R; GHIDINA M; FERRANDO A; CORTIGLIANI L; MERLETTI F; GREGORI D
Inhaled corticosteroids and bronchodilators for severe and very severe COPD patients: cost-effectiveness and health care budget impact in Italy
2005-01-01 Pradelli L; Iannazzo S; Dal Negro RW; Eandi M.
PCN350 - EVALUATION OF DISEASE-SPECIFIC SKIN SYMPTOM ITEMS ON SKINDEX-29 IN CUTANEOUS T-CELL LYMPHOMA PATIENTS TREATED WITH MOGAMULIZUMAB OR VORINOSTAT
2018-01-01 QUAGLINO, P
Prevention with picotamide and aspirin in patients with type 2 diabetes mellitus and peripheral arterial disease: a pharmacoeconomic evaluation
2006-01-01 Eandi M; Iannazzo S; Pradelli L.
THE RISK OF METABOLIC DISORDERS IN PATIENTS TREATED WITH ASENAPINE OR OLANZAPINE: A REAL WORLD DATA STUDY CONDUCTED IN ITALY AND SPAIN
2014-01-01 Maina, Giuseppe; Ripellino, C; Pegoraro, V; Caresano, C.
The Application Of Health Tecnology Assessment On The New Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine In Italy.
2009-01-01 La Torre G; Capri S; Castiglia P; Anessi Pessina E; Sacchini D; Marocco A; Gualano MR; Mannocci A; Nicolotti N; Ricciardi W
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile